FACTORS ASSOCIATED WITH PERSISTENCE OF HPV GENITAL INFECTION IN A SMALL COHORT OF ROMANIAN WOMEN.


Journal

Acta clinica Croatica
ISSN: 1333-9451
Titre abrégé: Acta Clin Croat
Pays: Croatia
ID NLM: 9425483

Informations de publication

Date de publication:
Sep 2019
Historique:
entrez: 24 1 2020
pubmed: 24 1 2020
medline: 18 4 2020
Statut: ppublish

Résumé

The aim of the study was to assess the role of behavioral factors in persistence of human papillomavirus (HPV) genital infection. Out of a cohort of 605 women included in a study of HPV infection prevalence, 142 HPV positive women (aged 18-57) were retested after a 12-month interval. None of the patients underwent surgical treatment during that period. Selected patients were asked for a second smear for cytologic analysis and HPV genotyping. A questionnaire that included information regarding reproductive health, sexual activity and smoking status was filled-in. After 12 months, 46 of 142 (32.39%) women had persistent HPV infection, with genotypes 16 and 18 found in 27 cases. On the other hand, 17 of 142 (11.97%) women had acquired new infections replacing the baseline genotypes. In our study, smoking (OR=2.320, p=0.0330) and sexual behavior (OR=5.333, p=0.0180 for more than three sexual partners; OR=2.427, p=0.0238 for cases where the partner was involved in another sexual relationship) were associated with viral persistence, while long-term contraception did not yield statistically significant results.

Identifiants

pubmed: 31969751
doi: 10.20471/acc.2019.58.03.02
pii: acc-58-410
pmc: PMC6971790
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

410-416

Références

APMIS. 2011 Jan;119(1):1-9
pubmed: 21143521
J Med Virol. 2008 Aug;80(8):1434-40
pubmed: 18551620
J Natl Cancer Inst Monogr. 2003;(31):20-8
pubmed: 12807941
Acta Clin Croat. 2017 Sep;56(3):369-374
pubmed: 29479901
Arch Pathol Lab Med. 2003 Aug;127(8):930-4
pubmed: 12873163
Nat Rev Immunol. 2002 May;2(5):372-7
pubmed: 12033743
Nat Rev Cancer. 2007 Jan;7(1):11-22
pubmed: 17186016
J Natl Cancer Inst. 2009 Jan 21;101(2):88-99
pubmed: 19141778
Gynecol Obstet Fertil. 2008 Apr;36(4):430-40
pubmed: 18417407
Int J Cancer. 2016 Jan 15;138(2):361-8
pubmed: 26238558
J Natl Cancer Inst. 2011 Mar 2;103(5):368-83
pubmed: 21282563
Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S2-5
pubmed: 17938014
J Natl Cancer Inst. 2002 Nov 6;94(21):1604-13
pubmed: 12419786
Eur J Gynaecol Oncol. 2005;26(5):491-8
pubmed: 16285563
CMAJ. 2001 Apr 3;164(7):1017-25
pubmed: 11314432
J Natl Compr Canc Netw. 2008 Jan;6(1):83-95
pubmed: 18267061
N Engl J Med. 1998 Feb 12;338(7):423-8
pubmed: 9459645
Am J Obstet Gynecol. 2000 Feb;182(2):257-64
pubmed: 10694321
Vaccine. 2008 Aug 19;26 Suppl 10:K1-16
pubmed: 18847553
N Engl J Med. 2003 Feb 6;348(6):518-27
pubmed: 12571259
J Pathol. 2006 Jan;208(2):152-64
pubmed: 16362994
Clin Microbiol Rev. 2003 Jan;16(1):1-17
pubmed: 12525422
Gynecol Oncol. 2003 Aug;90(2):358-65
pubmed: 12893200
Arch Virol. 2014 Dec;159(12):3305-20
pubmed: 25143263

Auteurs

Irina Huică (I)

1Molecular Virology Department, St. S. Nicolau Institute of Virology, Bucharest, Romania; 2Grigore T. Popa University of Medicine and Pharmacy, Iasi, Cuza Voda Obstetrics and Gynecology Clinical Hospital, Iasi, Romania.

Iulia Virginia Iancu (IV)

1Molecular Virology Department, St. S. Nicolau Institute of Virology, Bucharest, Romania; 2Grigore T. Popa University of Medicine and Pharmacy, Iasi, Cuza Voda Obstetrics and Gynecology Clinical Hospital, Iasi, Romania.

Anca Botezatu (A)

1Molecular Virology Department, St. S. Nicolau Institute of Virology, Bucharest, Romania; 2Grigore T. Popa University of Medicine and Pharmacy, Iasi, Cuza Voda Obstetrics and Gynecology Clinical Hospital, Iasi, Romania.

Adriana Pleşa (A)

1Molecular Virology Department, St. S. Nicolau Institute of Virology, Bucharest, Romania; 2Grigore T. Popa University of Medicine and Pharmacy, Iasi, Cuza Voda Obstetrics and Gynecology Clinical Hospital, Iasi, Romania.

Demetra Socolov (D)

1Molecular Virology Department, St. S. Nicolau Institute of Virology, Bucharest, Romania; 2Grigore T. Popa University of Medicine and Pharmacy, Iasi, Cuza Voda Obstetrics and Gynecology Clinical Hospital, Iasi, Romania.

Sergiu Teleman (S)

1Molecular Virology Department, St. S. Nicolau Institute of Virology, Bucharest, Romania; 2Grigore T. Popa University of Medicine and Pharmacy, Iasi, Cuza Voda Obstetrics and Gynecology Clinical Hospital, Iasi, Romania.

Gabriela Anton (G)

1Molecular Virology Department, St. S. Nicolau Institute of Virology, Bucharest, Romania; 2Grigore T. Popa University of Medicine and Pharmacy, Iasi, Cuza Voda Obstetrics and Gynecology Clinical Hospital, Iasi, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH